Literature DB >> 28975499

Is it time to reassess the role of myocardial metabolic modulation for the treatment of heart failure?

John P Bois1, Robert J Gropler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28975499     DOI： 10.1007/s12350-017-1068-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  28 in total

Review 1.  Evolving Concepts of Myocardial Energy Metabolism: More Than Just Fats and Carbohydrates.

Authors:  Gary D Lopaschuk; John R Ussher
Journal:  Circ Res       Date:  2016-11-11       Impact factor: 17.367

2.  Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.

Authors:  Helena Tuunanen; Erik Engblom; Alexandru Naum; Mika Scheinin; Kjell Någren; Juhani Airaksinen; Pirjo Nuutila; Patricia Iozzo; Heikki Ukkonen; Juhani Knuuti
Journal:  J Card Fail       Date:  2006-10       Impact factor: 5.712

3.  Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.

Authors:  Anders Jorsal; Caroline Kistorp; Pernille Holmager; Rasmus Stilling Tougaard; Roni Nielsen; Anja Hänselmann; Brian Nilsson; Jacob Eifer Møller; Jakob Hjort; Jon Rasmussen; Trine Welløv Boesgaard; Morten Schou; Lars Videbaek; Ida Gustafsson; Allan Flyvbjerg; Henrik Wiggers; Lise Tarnow
Journal:  Eur J Heart Fail       Date:  2016-10-28       Impact factor: 15.534

4.  Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.

Authors:  M Gejl; H M Søndergaard; C Stecher; B M Bibby; N Møller; H E Bøtker; S B Hansen; A Gjedde; J Rungby; B Brock
Journal:  J Clin Endocrinol Metab       Date:  2012-04-27       Impact factor: 5.958

5.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

6.  Impact of gender on the myocardial metabolic response to obesity.

Authors:  Linda R Peterson; Pablo F Soto; Pilar Herrero; B Selma Mohammed; Michael S Avidan; Kenneth B Schechtman; Carmen Dence; Robert J Gropler
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

7.  Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.

Authors:  Kiwon Ban; M Hossein Noyan-Ashraf; Judith Hoefer; Steffen-Sebastian Bolz; Daniel J Drucker; Mansoor Husain
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

8.  Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.

Authors:  Robert N Doughty; Gillian A Whalley; Helen A Walsh; Greg D Gamble; José López-Sendón; Norman Sharpe
Journal:  Circulation       Date:  2004-01-05       Impact factor: 29.690

9.  GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.

Authors:  Mohammad Hossein Noyan-Ashraf; M Abdul Momen; Kiwon Ban; Al-Muktafi Sadi; Yu-Qing Zhou; Ali M Riazi; Laurie L Baggio; R Mark Henkelman; Mansoor Husain; Daniel J Drucker
Journal:  Diabetes       Date:  2009-01-16       Impact factor: 9.461

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.